ESPL1 and carcinoma: On the other hand, approximately 50% compound heterozygote (ESPL1+/hyp, p53+/−) animals developed carcinomas over a period of 460 days (about 14 months), compared to p53+/− animals, a much smaller percentage of which developed a significant tumor phenotype over the same time period.